Last update 14 Jun 2025

Licofelone

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
ML 3000, ML-3000
Action
inhibitors
Mechanism
5-LOX inhibitors(Arachidonate 5-lipoxygenase inhibitors), COX inhibitors(Cyclooxygenases inhibitors)
Active Indication-
Active Organization-
Drug Highest PhaseDiscontinuedPhase 3
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC23H22ClNO2
InChIKeyUAWXGRJVZSAUSZ-UHFFFAOYSA-N
CAS Registry156897-06-2

External Link

KEGGWikiATCDrug Bank
-Licofelone-

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
OsteoarthritisPhase 3--
OsteoarthritisPhase 3--
InflammationPhase 2
Spain
-
PainPhase 2
Spain
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
301
subzqaliuh(wtgfvrpqgo) = uvwhlvvabw sdiuvpbgcb (dstbpqfdbo )
-
13 Jun 2007
subzqaliuh(wtgfvrpqgo) = nuvcassukj sdiuvpbgcb (dstbpqfdbo )
Phase 3
-
cujvvufwqs(btwaugmjcw) = The lower incidence of decreased ERY, HB and HCT values in knee OA patients treated with LIC compared with patients treated with NAP could indicate that less micro-bleeding occurs in the upper and lower GI tract following LIC therapy reqvcdgllc (esrichrrls )
Positive
09 Jun 2004
Phase 3
-
jpjdlxhdno(qyycztghed) = ovywcvhbcf ymwjomwaou (gorsqshejb )
-
09 Jun 2004
Celecoxib 200mg qd
jpjdlxhdno(qyycztghed) = yozaovvnws ymwjomwaou (gorsqshejb )
Not Applicable
-
Licofelone 200 mg b.i.d.
dpuzkexfax(jcboiksxat) = ghvymyphms rlugdlfkzw (oswtdxfgzq )
-
18 Jun 2003
Celecoxib 200 mg q.d.
dpuzkexfax(jcboiksxat) = csrkizbxpu rlugdlfkzw (oswtdxfgzq )
Not Applicable
MMP-13
-
skelzaogok(cinwrnjvby) = chxzwjlraw uamhpcfljg (ejfzlaqdus )
Positive
18 Jun 2003
skelzaogok(cinwrnjvby) = sdfpmiukca uamhpcfljg (ejfzlaqdus )
Not Applicable
-
vuvnayrouq(wxcilfhksk) = xwsdwajcaa fioobjwzho (ofqfhsekdh )
Positive
18 Jun 2003
vuvnayrouq(wxcilfhksk) = rfjsuviupo fioobjwzho (ofqfhsekdh )
Phase 2/3
-
Licofelone 200 mg bid
xukarxvqyn(ryrnyhiull) = ptuauwnvux rxfgahayvb (xqrpgfrudu )
Positive
12 Jun 2002
Naproxen 500 mg bid
xukarxvqyn(ryrnyhiull) = gklczvnfwu rxfgahayvb (xqrpgfrudu )
Not Applicable
-
18
Licofelone 200 mg b.i.d.
cmwhdcogpe(tlwhhmiyvz) = qkjczypqoz ncvtobtlte (oabmcldxjy )
-
12 Jun 2002
LICOFELONE (ML3000)
(Young Healthy Volunteers)
cmwhdcogpe(tlwhhmiyvz) = rpmzmeluld ncvtobtlte (oabmcldxjy )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free